American News
US tariffs on India will be a bitter pill to swallow
With Donald Trump’s tit-for-tat tariffs on India looming next month, millions of Americans may have to brace for steeper medical bills.
Last week, Indian Commerce MinisterPiyush Goyal made an unscheduled trip to the US for discussions with officials, hoping to strike a trade deal.
It followed Trump’s announcement that he would impose tariffs – which are government taxes on foreign imports – on India by 2 April, in retaliation to India’s tariffs on American goods.
Goyal wants to stave off tax increases on India’s critical export industries like medicinal drugs.
Nearly half of all generic medicines taken in the US come from India alone. Generic drugs – which are cheaper versions of brand-name medications – imported from countries like India make up nine out of 10 prescriptions in the US.
This saves Washington billions in healthcare costs. In 2022 alone, the savings from Indian generics amounted to a staggering $219bn (£169bn),according to a study by consulting firm IQVIA.
Without a trade deal, Trump’s tariffs could make some Indian generics unviable, forcing companies to exit part of the market and exacerbating existing drug shortages, experts say.
Tariffs could “worsen the demand-supply imbalances” and the uninsured and poor will be left counting the costs, says Dr Melissa Barber, a drug costing expert from Yale University.
The effects could be felt across people suffering from a range of health conditions.
Over 60% of prescriptions for hypertension and mental health ailments in the US were filled with Indian-made drugs, according to the IQVIA study funded by the Indian Pharmaceutical Alliance (IPA).
Sertraline, the most prescribed antidepressant in the US, is a prominent example of how dependent Americans are on Indian supplies for essential drugs.
Many of them cost half as much as those from non-Indian companies.
“We are worried about this,” says Peter Maybarduk, a lawyer at Public Citizens, a consumer advocacy group fighting for access to medicines. One in four American patients fail to take medicines due to their costs, he adds.
Trump is already reportedly facing pressure from US hospitals and generic drugmakers because of his tariffs on Chinese imports.
The raw materials for 87% of the drugs sold in the US are located outside the country and primarily concentrated in China which fulfils around 40% of global supply.
With tariffs on Chinese imports rising 20% since Trump took office, the cost of raw materials for drugs has already gone up.

Trump wants companies to shift manufacturing to the US to avoid his tariffs.
Big pharma giants like Pfizer and Eli Lily, that sell brand name and patented drugs, have said they are committing to move some manufacturing there.
But the economics for low-value drugs do not add up.
Dilip Shanghvi, chairman of India’s largest drugmaker Sun Pharma, told an industry gathering last week that his company sells pills for between $1 and $5 per bottle in the US and tariffs “do not justify relocating our manufacturing to the US”.
“Manufacturing in India is at least three to four times cheaper than in the US,” says Sudarshan Jain of the IPA.
Any quick relocation will be next to impossible. Building a new manufacturing facility can cost up to $2bn and take five to 10 years before it is operational, according to lobby group PhRMA.

For local pharma players in India, the tariff blow could be brutal too.
The pharmaceutical sector is India’s largest industrial export according to GTRI, a trade research agency.
India exports some $12.7bn worth of drugs to the US annually, paying virtually no tax. US drugs coming into India, however, pay 10.91% in duties.
This leaves a “trade differential” of 10.9%. Any reciprocal tariffs by the US would increase the costs for both generic medicines and specialty drugs, according to GTRI.
It flags up pharmaceuticals as one of the sectors that is most vulnerable to price increases in the US market.
Indian firms which largely sell generic drugs already work on thin margins and won’t be able to afford a steep tax outgo.
They sell at much lower prices compared to competing peers, and have steadily gained dominance across cardiovascular, mental health, dermatology and women’s health drugs in the world’s largest pharma market.
“We can offset single-digit tariff hikes with cost cuts, but anything higher will have to be passed down to consumers,” the finance head of a top Indian drugmaker who didn’t want to be identified, told the BBC.
North America is their biggest revenue source, contributing a third of the earnings and profitability of most companies.
“It is the fastest growing market and most crucial. Even if we increase exposure to other markets, it will not adjust for any loss in the US market,” the finance head said.
Umang Vohra, CEO of India’s third-largest drug firm Cipla, said at a public gathering recently that tariffs should not ultimately dictate what businesses do, “because there is a risk that four years later, those tariffs may go away”.
But four years is a long time, and could make or break the fortunes of several companies.
To avoid any of this, “India should just drop its tariffs on pharma goods”, Ajay Bagga, a veteran market expert told the BBC. “US drug exports into India are barely half a billion dollars, so the impact will be negligible.”
The IPA, which consists of India’s largest drug makers, has also recommended zero duty on US drug exports so that India isn’t negatively impacted by reciprocal levies.
Indian Prime Minister Narendra Modi’s government recently added 36 life-saving drugs to the list of medicines fully exempted from a basic customs duty in the budget, and President Trump dropped a hint last week that India could be yielding to his pressure.
India has agreed to cut tariffs “way down”, he said, because “somebody is finally exposing them for what they have done”.
Delhi has not responded yet, but pharma players in both countries are nervously waiting to see the specifics of a trade deal that could have a bearing on lives and livelihoods.
“In the short term, there may be some pain through new tariffs, but I think they’ll make significant progress by the fall of this year for a first tranche [trade] agreement,” Mark Linscott, Senior Advisor at US-India Strategic Partnership Forum, told the BBC, adding that neither country could afford a breakdown in pharma supply chains.
Taken From BBC News
American News
Conservative justices sharply question Trump tariffs in high stakes hearing
Donald Trump’s sweeping use of tariffs in the first nine months of his second term was sharply questioned during oral arguments before the Supreme Court on Wednesday.
Chief Justice John Roberts, and justices Amy Coney Barrett and Neil Gorsuch – three conservative jurists considered swing votes in this case – peppered US Solicitor General John Sauer, representing the president’s administration before the court.
They were joined by the court’s three liberal justices, who also expressed scepticism about whether federal law – and the US Constitution – give the president authority to unilaterally set tariff levels on foreign imports.
“The justification is being used for power to impose tariffs on any product from any country in any amount, for any length of time,” Roberts said.
If the court ruled for Trump in this case, Gorsuch wondered: “What would prohibit Congress from just abdicating all responsibility to regulate foreign commerce?”
He added that he was “struggling” to find a reason to buy Sauer’s arguments.
In a possible sign of case’s complexities, the hearing stretched almost three hours – far longer than the time formally allotted.
Arguing over ‘country-killing’ crises
The case centres around a 1977 law, the International Emergency Economic Powers Act (IEEPA), that Trump’s lawyers have said gives the president the power to impose tariffs. Although the Constitution specifically vests Congress with tariff authority, Trump has claimed that the legislature delegated “emergency” authority to him to bypass longer, established processes.
Sauer asserted that the nation faced unique crises – ones that were “country-killing and not sustainable” – that necessitated emergency action by the president. He warned that if Trump’s tariff powers were ruled illegal, it would expose the US to “ruthless trade retaliation” and lead to “ruinous economic and national security consequences”.
Trump first invoked IEEPA in February to tax goods from China, Mexico and Canada, saying drug trafficking from those countries constituted an emergency.
He deployed it again in April, ordering levies from 10% to 50% on goods from almost every country in the world. This time, he said the US trade deficit – where the US imports more than it exports – posed an “extraordinary and unusual threat”.
Those tariffs took hold in fits and starts this summer while the US pushed countries to strike “deals”.
Lawyers for the challenging states and private groups have contended that while the IEEPA gave the president power to regulate trade, it made no mention of the word “tariffs”.
Neil Katyal, making the case for the private businesses, said it was “implausible” that Congress “handed the president the power to overhaul the entire tariff system and the American economy in the process, allowing him to set and reset tariffs on any and every product from any and every country, at any and all times”.
He also challenged whether the issues cited by the White House, especially the trade deficit, represent the kind of emergencies the law envisioned.
Suppose America faced the threat of war from a “very powerful enemy”, Samuel Alito, another conservative justice, asked. “Could a president under this provision impose a tariff to stave off war?”
Katyal said that a president could impose an embargo or a quota, but a revenue-raising tariff was a step too far.
For Sauer, this was a false choice. Presidents, he said, have broad powers over national security and foreign policy – powers that the challengers want to infringe on.
Tariffs v taxes
A key question could be whether the court determines whether Trump’s tariffs are a tax.
Several justices pointed out that the power to tax – to raise revenue – is explicitly given to Congress in the Constitution.
Sauer’s reply was that Trump’s tariffs are a means of regulating trade and that any revenue generated is “only incidental”.
Of course, Trump himself has boasted about the billions his tariffs have generated so far and how essential this new stream of funding is to the federal government.
The justices spent very little time on questions about refunds or whether the president’s emergency declarations were warranted. Instead they spent most of their time examining the text of IEEPA and its history.
Sauer urged them to understand tariffs as a natural extension of other powers granted to the president under the law rather than a tax. “I can’t say it enough – it is a regulatory tariff, not a tax,” he said.
But that appeared to be a stumbling block for many of the justices.
“You want to say that tariffs are not taxes but that’s exactly what they are,” Justice Sotomayor said.
Many seemed persuaded by arguments from the business and states that tariffs, as a tax paid by US businesses, were fundamentally different from the other kinds of powers addressed by the law.
But not all.
Justice Kavanaugh expressed doubts on that point toward the end of the hearing, saying it didn’t seem to very “common sense” to give the president the power to block trade entirely, but not impose a 1% tariff, sugggesting it left a gap like a donut hole.
“It’s not a donut hole. It’s a different kind of pastry,” Gutman responded, drawing chuckles in the crowd.
What the court’s ruling could do
Treasury Secretary Scott Bessent, who attended the hearing, made no comment when asked by the BBC what he thought of the hearing. Secretary of Commerce Howard Lutnick, also in court, flashed a thumbs-up.
US Trade Envoy Jamieson Greer was in court, along with Minnesota Senator Amy Klobuchar, who said outside after arguments that she was “hopeful” based on the questions asked that the court would overturn the tariffs.
“I thought they were very good questions,” she said, describing tariffs as an “unconstitutional power grab” by the president.
The hearing drew a full audience, with press pushed into overflow seats behind columns.
If a majority of the Supreme Court rules in Trump’s favour, it will overturn the findings of three lower courts that already ruled against the administration.
The decision, no matter how it works out, has implications for an estimated $90bn worth of import taxes already paid – roughly half the tariff revenue the US collected this year through September, according to Wells Fargo analysts.
Trump officials have warned that sum could swell to $1tn if the court takes until June to rule.
During oral arguments, Barrett grappled with the question of reimbursing such revenue, wondering if it would be a “complete mess”.
Katyal responded by saying that small businesses might get refunds, but bigger companies would have to follow “administrative procedures”. He admitted that it was a “very complicated thing”.
In remarks on Wednesday, press secretary Karoline Leavett hinted that the administration already is looking at other ways to impose tariffs if the Supreme Court rules against them.
“The White House is always preparing for Plan B,” she said. “It would be imprudent of the president’s advisors not to prepare for such a situation.”
American News
Canada Ad That Rattled Trump
Paris (Imran Y. CHOUDHRY) :- Former Press Secretary to the President, Former Press Minister to the Embassy of Pakistan to France, Former MD, SRBC Mr. Qamar Bashir analysis : In October 2025, a seemingly harmless Canadian public-service announcement featuring Ronald Reagan’s 1987 speech on tariffs ignited an international political storm. What began as a provincial media campaign by Ontario quickly escalated into a full-blown trade confrontation with the United States—one that exposed the fragility of U.S.–Canada relations in the Trump era and the fine line between political messaging and economic provocation.
The ad opened with archival footage of Reagan declaring, “Protectionism is destructionism. Tariffs and quotas are barriers that protect the few at the expense of the many.” The message, originally delivered at the height of the Cold War, was reinterpreted by Ontario’s communications bureau as a critique of modern tariff nationalism. The closing frame read, “Free trade built North America. Tariffs break it.” The timing was deliberate. It aired just days after President Donald J. Trump announced a 5% tariff increase on Canadian steel, aluminum, and agricultural imports—part of his renewed “America First Fair Trade” agenda.
For Trump, the ad wasn’t merely a disagreement over policy; it was personal. The president viewed the Reagan montage as a deliberate distortion of a conservative icon’s legacy—one that painted Trump as an economic isolationist rather than a nationalist reformer. Within hours of the broadcast, the White House communications team condemned the ad as “foreign political interference in U.S. policy discourse.” Trump himself took to Truth Social, writing: “Fake Reagan quotes, fake Canada leadership. We’re done talking until they apologize. New tariffs coming.”
The fallout was swift. Trump’s administration suspended ongoing trade negotiations aimed at refining the U.S.–Canada Economic Partnership Framework. He ordered a 10% across-the-board tariff increase on all Canadian imports, including automotive parts, lumber, dairy, and consumer goods. For two economies intertwined through $800 billion in annual trade, the move sent shockwaves through industries on both sides of the border. Trucking associations, small exporters, and retail chains immediately warned that price hikes were inevitable before the 2025 holiday season.
In Ottawa, Prime Minister Mark Carney acted quickly to contain the crisis. Although the advertisement originated from Ontario’s provincial government rather than the federal cabinet, Trump’s reaction forced Ottawa to intervene. In a carefully worded statement, Carney expressed “regret for any misunderstanding” and emphasized that “the ad does not reflect Canada’s federal stance on U.S. trade policy.” According to The Washington Post, Carney even reached out to Trump personally to offer an apology—an unusual act in modern diplomacy that underscored how high the stakes were.
Trump acknowledged the apology publicly but refused to lift the suspension of trade talks. “I appreciate Prime Minister Carney’s words,” he said during a Mar-a-Lago press briefing. “But actions speak louder than apologies. We’ll see if Canada really wants fair trade—not propaganda.”
The ad’s creators defended their intent, claiming it was meant to “highlight the historical value of free trade” rather than criticize Trump personally. Yet political analysts in both countries saw it as a textbook case of how symbolic gestures can spiral into real-world consequences. “Reagan’s words were about global cooperation against communism, not about contemporary tariff disputes,” explained Professor Samuel Pritchard of the University of Toronto. “Re-contextualizing them during an active negotiation with a protectionist White House was politically reckless, even if rhetorically clever.”
Canadian citizens were deeply divided. Some praised Ontario for “standing up for free trade principles,” seeing it as a proud reaffirmation of Reagan-era conservatism and cross-border partnership. Others accused the provincial government of jeopardizing livelihoods for political theater. Social-media platforms were soon flooded with hashtags such as #ReaganAdGate and #TariffWarNorth. Polls conducted by the Toronto Star indicated that 42% of Canadians supported the ad, while 47% thought it was ill-timed and diplomatically irresponsible.
For small business owners in Ontario and Quebec, the timing could not have been worse. Tariff hikes immediately disrupted auto-parts exports and timber shipments. The Canadian Chamber of Commerce estimated losses exceeding $2.4 billion within the first two weeks of the new tariff regime. The Toronto Stock Exchange saw its manufacturing index fall by nearly 4% in a single day—its steepest drop since early 2023.
In the United States, the political narrative was equally polarized. Trump’s supporters hailed the move as evidence of his “uncompromising defense of American workers,” while his critics accused him of hypersensitivity and using trade policy to punish political speech abroad. Several U.S. senators from border states, including Michigan and New York, quietly urged the administration to de-escalate, citing mounting pressure from local businesses dependent on cross-border supply chains.
Mark Carney’s apology, intended as a pragmatic gesture, triggered heated debate in Canada’s Parliament. Opposition leader Pierre Poilievre accused the prime minister of “bowing to American intimidation” and undermining Canadian sovereignty. Carney countered that leadership demanded “preventing a rhetorical dispute from turning into an economic war.” His cautionary tone reflected the grim reality that Canada could ill afford another prolonged tariff standoff, especially after years of global inflation and energy-price volatility.
Meanwhile, the United States began leveraging the dispute in broader trade negotiations with Europe and Mexico, signaling that Washington was prepared to use tariffs not merely as economic tools but as instruments of political discipline. Analysts warned that such tactics risked eroding trust even among America’s closest allies. The Reagan-ad episode, they argued, revealed how fragile diplomatic etiquette had become in an era of social-media-driven politics and impulsive leadership.
For historians, the irony was impossible to miss. Ronald Reagan—whose words were meant to defend free markets—had unintentionally become the centerpiece of a 21st-century trade war. The contrast between Reagan’s optimism and Trump’s transactional realism encapsulated a profound shift in American conservatism: from a belief in open exchange to a strategy rooted in economic nationalism and leverage.
The “Reagan Ad Affair,” as international media dubbed it, may one day be remembered less for its economic cost and more for its symbolic power. It captured a moment when an old speech from the Cold War could still shake the foundations of modern diplomacy—when images, not policies, defined the fate of nations. In an age where political theater travels faster than policy restraint, one provincial ad in Canada became a global lesson in the perilous intersection of media, ego, and economics.
American News
Trump’s planned tests are ‘not nuclear explosions’, US energy secretary says
The US is not planning to conduct nuclear explosions, Energy Secretary Chris Wright has said, calming global concerns after President Donald Trump called on the military to resume weapons testing.
“These are not nuclear explosions,” Wright told Fox News on Sunday. “These are what we call non-critical explosions.”
The comments come days after Trump wrote on Truth Social that he had directed defence officials to “start testing our nuclear weapons on an equal basis” with rival powers.
But Wright, whose agency oversees testing, said people living in the Nevada desert should have “no worries” about seeing a mushroom cloud.
“Americans near historic test sites such as the Nevada National Security Site have no cause for concern,” Wright said. “So you’re testing all the other parts of a nuclear weapon to make sure they deliver the appropriate geometry, and they set up the nuclear explosion.”
Trump’s comments on Truth Social last week were interpreted by many as a sign the US was preparing to restart full-scale nuclear blasts for the first time since 1992.
In an interview with 60 Minutes on CBS, which was recorded on Friday and aired on Sunday, Trump reiterated his position.
“I’m saying that we’re going to test nuclear weapons like other countries do, yes,” Trump said when asked by CBS’s Norah O’Donnell if he planned for the US to detonate a nuclear weapon for the first time in more than 30 years.
“Russia’s testing, and China’s testing, but they don’t talk about it,” he added.
Russia and China have not carried out such tests since 1990 and 1996 respectively.
Pressed further on the topic, Trump said: “They don’t go and tell you about it.”
“I don’t want to be the only country that doesn’t test,” he said, adding North Korea and Pakistan to the list of nations allegedly testing their arsenals.
On Monday, China’s foreign ministry denied conducting nuclear weapons tests.
As a “responsible nuclear-weapons state, China has always… upheld a self-defence nuclear strategy and abided by its commitment to suspend nuclear testing”, spokeswoman Mao Ning said at a regular press conference in Beijing.
She added that China hoped the US would “take concrete actions to safeguard the international nuclear disarmament and non-proliferation regime and maintain global strategic balance and stability”.
On Thursday, Russia too denied it had carried out nuclear tests.
“Regarding the tests of Poseidon and Burevestnik, we hope that the information was conveyed correctly to President Trump,” Kremlin spokesman Dmitry Peskov told journalists, referencing the names of Russian weapons. “This cannot in any way be interpreted as a nuclear test.”
North Korea is the only country that has carried out nuclear testing since the 1990s – and even Pyongyang announced a moratorium in 2018.
The exact number of nuclear warheads held by each country is kept secret in each case – but Russia is thought to have a total of about 5,459 warheads while the US has about 5,177, according to the Federation of American Scientists (FAS).
The US-based ACA gives slightly higher estimates, saying America’s nuclear stockpile sits at about 5,225 warheads, while Russia has approximately 5,580.
China is the world’s third largest nuclear power with about 600 warheads, France has 290, the United Kingdom 225, India 180, Pakistan 170, Israel 90 and North Korea 50, the FAS says.
According to US think tank Center for Strategic and International Studies (CSIS), China has roughly doubled its nuclear arsenal in the past five years and is expected to exceed 1,000 weapons by 2030.
-
Europe News8 months agoChaos and unproven theories surround Tates’ release from Romania
-
American News8 months agoTrump Expels Zelensky from the White House
-
American News8 months agoTrump expands exemptions from Canada and Mexico tariffs
-
American News8 months agoZelensky bruised but upbeat after diplomatic whirlwind
-
Art & Culture8 months agoThe Indian film showing the bride’s ‘humiliation’ in arranged marriage
-
Art & Culture8 months agoInternational Agriculture Exhibition held in Paris
-
Politics8 months agoUS cuts send South Africa’s HIV treatment ‘off a cliff’
-
Politics8 months agoWorst violence in Syria since Assad fall as dozens killed in clashes
